Christopher David
Impact in
-
- Nanoparticle-Based Drug Delivery
-
- Advanced Drug Delivery Systems
Papers in
-
- Extracellular vesicles in disease 2
- Inflammasome and immune disorders 2
- Co-authors
- Neill J. Liptrott (13 shared papers)Andrew Owen (6 shared papers)Rob J. Vandebriel (3 shared papers)Matteo Santin (1 shared paper)Susanne Bremer‐Hoffmann (1 shared paper)Marco Siccardi (1 shared paper)Fanny Caputo (1 shared paper)Blanka Halamoda‐Kenzaoui (1 shared paper)
- Journals
- Journal of Lipid Research (3 papers)Biomedicine & Pharmacotherapy (3 papers)Pharmaceutics (2 papers)Cell & Bioscience (1 paper)Nanomedicine (1 paper)
- Partner nations
- United KingdomUnited StatesNetherlands
In The Last Decade
Christopher David
16 papers receiving 161 citations
Peers
Comparison fields: 5 of 66
- Biomaterials 41
- Pharmaceutical Science 18
- Immunology 30
- Infectious Diseases 21
- Molecular Medicine 5
Countries citing papers authored by Christopher David
This map shows the geographic impact of Christopher David's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher David with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher David more than expected).
Fields of papers citing papers by Christopher David
This network shows the impact of papers produced by Christopher David. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher David. The network helps show where Christopher David may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher David, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 54 | |
| 2 | 2016 | 25 | |
| 3 | 2004 | 19 | |
| 4 | 2021 | 14 | |
| 5 | 2020 | 11 | |
| 6 | 2021 | 10 | |
| 7 | 2022 | 6 | |
| 8 | 2022 | 4 | |
| 9 | 2023 | 4 | |
| 10 | 2023 | 3 | |
| 11 | 2023 | 3 | |
| 12 | 2004 | 3 | |
| 13 | 2022 | 3 | |
| 14 | 2021 | 3 | |
| 15 | 2004 | 2 | |
| 16 | 2023 | 1 |
About Christopher David
Christopher David is a scholar working on Immunology, Molecular Biology, Infectious Diseases, Materials Chemistry and Surgery, having authored 16 papers that have together received 165 indexed citations. Recurring topics across this work include Nanoparticles: synthesis and applications (3 papers), HIV Research and Treatment (2 papers), COVID-19 Clinical Research Studies (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Extracellular vesicles in disease (2 papers), Inflammasome and immune disorders (2 papers), HIV/AIDS drug development and treatment (2 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (1 paper). The work is most often cited by research in Biomaterials (41 citations), Pharmaceutical Science (18 citations), Immunology (30 citations), Infectious Diseases (21 citations) and Molecular Medicine (5 citations). Christopher David has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Neill J. Liptrott, Andrew Owen, Rob J. Vandebriel, Matteo Santin, Susanne Bremer‐Hoffmann, Marco Siccardi, Fanny Caputo, Blanka Halamoda‐Kenzaoui, Sven Even Borgos and Sungshin Choi. Their work appears in journals such as Journal of Lipid Research, Biomedicine & Pharmacotherapy, Pharmaceutics, Cell & Bioscience and Nanomedicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.